Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials.

Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials.

Item
http://www.wikidata.org/entity/Q31050197
Adoptive immunotherapy with interleukin-2 & induced killer cells in non-small cell lung cancer: A systematic review & meta-analysisThe efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis.Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis.Evaluation of tumour vaccine immunotherapy for the treatment of advanced non-small cell lung cancer: a systematic meta-analysis.Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer.Potential role of immunotherapy in advanced non-small-cell lung cancerCurrent adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome.Comparative beneficiary effects of immunotherapy against chemotherapy in patients with advanced NSCLC: Meta-analysis and systematic review.Immunotherapy for Non-small-cell Lung Cancer: Current Status and Future Obstacles.[Review on immunotherapies for lung cancer].
P2860

Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials.

Item
http://www.wikidata.org/entity/Q31050197
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Strengths and weaknesses of im ...... randomized controlled trials.
@ast
Strengths and weaknesses of im ...... randomized controlled trials.
@en
type
label
Strengths and weaknesses of im ...... randomized controlled trials.
@ast
Strengths and weaknesses of im ...... randomized controlled trials.
@en
prefLabel
Strengths and weaknesses of im ...... randomized controlled trials.
@ast
Strengths and weaknesses of im ...... randomized controlled trials.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Strengths and weaknesses of im ...... randomized controlled trials.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0032695
P407
P433
P478
P577
P5875
P698
P921
P932